JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


501	Wed, 8/3/2011, 10:30 AM - 12:20 PM	CC-D241
Statistical Considerations in Bioequivalence, Therapeutic Equivalence, Biosimilarity, and Noninferiority Investigations — Topic Contributed Papers
Biopharmaceutical Section , ENAR
Organizer(s): Kallappa M. Koti, U.S. Food and Drug Administration
Chair(s): Mark A. Gamalo, U.S. Food and Drug Administration/CDER/OTS/OB
10:35 AM	Evaluating Bioequivalence of Two AUCs Obtained from Sparse or Incomplete Sampling in Parallel Designs — Steven Hua, Pfizer Inc. ; Jihao Zhou, Pfizer Inc.
10:55 AM	Stratified Analysis of Bioequivalence and Therapeutic Equivalence Trials Data When the Metric Is Ratio of Parameters — Kallappa M. Koti, U.S. Food and Drug Administration
11:15 AM	On Analysis of the Difference of Two Exposure-Adjusted Poisson Rates — Ivan S. F. Chan, Merck Research Laboratories ; William W. B. Wang, Merck Research Laboratories
11:35 AM	Assessing Noninferiority in Multiregion Trial Using the Bayesian Approach — Satrajit Roychoudhury, Novartis
11:55 AM	Discussant: Debajyoti Sinha, Florida State University
12:15 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.